About
Dr. Gregory Grunberg joined Longitude Capital in 2012 as a Managing Director. He focuses on investments in medical devices and biotechnology. Prior to joining Longitude, Dr. Grunberg was a Principal at Rho Ventures, a multi-stage, multi-sector fund, where he participated in medical device, biotechnology and other healthcare investments. Before joining Rho, Dr. Grunberg was an Engagement Manager in the life sciences practice of McKinsey & Company. While at McKinsey, he worked with many large life sciences companies and private equity investors across a range of projects encompassing investment due diligence, business development, R&D, and product development. He also consulted at The Parthenon Group and led his own health care advisory firm during graduate school. Greg is a board-certified physician in Internal Medicine and completed his residency at Weill-Cornell’s New York Presbyterian Hospital. He has maintained a limited clinical practice in Internal Medicine and affiliations with
Position in the VCSift Database
- • 13 investors at Longitude Capital are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Gregory Grunberg is one of them.
- • 931 investors are based in Palo Alto, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Palo Alto, US
Contact Information
Find more investors like Gregory
Search Investors